Across TCGA pan-cancer cohorts, FUOM mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of FUOM’s most consistent transcriptional readouts.
The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where FUOM mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types FUOM is over-expressed in tumor, although a few such as CCRCC and LUAD show the opposite, repressed pattern.
CCRCC, LUAD, and HNSC are the cancer types where FUOM tumor–normal differential expression is most reproducible.